Coronavirus: Moderna to begin testing vaccine in children

Moderna to begin testing vaccine in children

Pharmaceutical company Moderna said Wednesday it will begin testing its vaccine in children.

The study will include 3,000 children aged 12 to 17 years old, The New York Times reported. Half will be given two shots of a vaccine four weeks apart and the others a placebo of salt water.

Content Continues Below

However, the trial is not yet accepting volunteers, Colleen Hussey, a Moderna spokeswoman, told the Times. A link to active test centers could become active Monday.

On Monday, Moderna said its vaccine is 94% effective in clinical trials. However vaccines can not be given to children until they are tested in them. Moderna’s vaccine still has not been tested in children and pregnant women.

More coronavirus pandemic coverage: